Glycemic IndexDepressionHemoglobin A, GlycosylatedBlood GlucoseHypoglycemic AgentsDiabetes Mellitus, Type 2HyperglycemiaDiabetes Mellitus, Type 1Blood Glucose Self-MonitoringInsulinHypoglycemiaDiabetic DietDepressive DisorderDiabetes MellitusMetforminDepression, PostpartumDietary CarbohydratesSulfonylurea CompoundsInsulin Infusion SystemsCortical Spreading DepressionFructosamineDepressive Disorder, MajorDiabetes ComplicationsInsulin, Long-ActingPostprandial PeriodSelf CareAntidepressive AgentsRisk FactorsTreatment OutcomeDipeptidyl-Peptidase IV InhibitorsPsychiatric Status Rating ScalesDiabetic AngiopathiesGlucagon-Like Peptide 1Long-Term Synaptic DepressionVenomsAnxietyQuestionnairesCross-Sectional StudiesInfusions, SubcutaneousGlipizideInsulin, IsophaneDiabetic NephropathiesC-PeptidePatient CompliancePancreas, ArtificialFollow-Up StudiesInsulin LisproPregnancy in DiabeticsMonitoring, PhysiologicTime FactorsThiazolidinedionesDiabetic RetinopathyGlucose Tolerance TestDiagnostic EquipmentInsulin ResistanceBody Mass IndexProspective StudiesCritical IllnessCritical CareLongitudinal StudiesCohort StudiesBiological MarkersSeverity of Illness IndexDiabetic KetoacidosisIncretinsComorbidityDisease ManagementDiabetes Mellitus, ExperimentalHyperglycemic Hyperosmolar Nonketotic ComaBody WeightFastingStress, PsychologicalDiabetic NeuropathiesObesityPersonality InventoryCross-Over StudiesGlycosuriaDrug Therapy, CombinationWeight LossAllylamineEpichlorohydrinLipidsGliclazideUnited StatesRegression AnalysisSodium-Glucose Transporter 2Monitoring, AmbulatoryPatient Education as TopicRetrospective StudiesPrevalenceAlbuminuriaInsulin-Secreting CellsAcarboseAdamantaneDouble-Blind MethodDietary FiberGlucoseLogistic ModelsVermontQuality of Life